Your session is about to expire
← Back to Search
Lung volume recruitment for Multiple Sclerosis
N/A
Waitlist Available
Led By Douglas A McKim, MD
Research Sponsored by Ottawa Hospital Research Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
* History of multiple sclerosis, diagnosed by a neurologist in accordance with the 2010 McDonald criteria
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up up to 5 years
Awards & highlights
Summary
Multiple sclerosis is a neurological disease that can affect lung function and cough efficacy. This pilot study will examine whether the lung volume recruitment technique can slow down the decline in lung function and cough.
Eligible Conditions
- Multiple Sclerosis
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ up to 5 years
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~up to 5 years
Treatment Details
Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Lung volume recruitmentExperimental Treatment1 Intervention
Lung volume recruitment twice daily for 9 months
Group II: Standard careActive Control1 Intervention
Standard care
Find a Location
Who is running the clinical trial?
The Ottawa HospitalOTHER
93 Previous Clinical Trials
63,007 Total Patients Enrolled
3 Trials studying Multiple Sclerosis
152 Patients Enrolled for Multiple Sclerosis
Ottawa Hospital Research InstituteLead Sponsor
572 Previous Clinical Trials
2,788,987 Total Patients Enrolled
2 Trials studying Multiple Sclerosis
55 Patients Enrolled for Multiple Sclerosis
Douglas A McKim, MDPrincipal InvestigatorThe Ottawa Hospital
Share this study with friends
Copy Link
Messenger